Intervention

Gamma-Secretase Inhibitor RO4929097

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials6
Recruiting0
Common conditions25
Lead sponsors shown1
Advertisement

Clinical trials

6 shown
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast CancerNCT01238133 · 2010-12-01
TERMINATED
RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast CancerNCT01217411 · 2010-10-01
TERMINATED
RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast CancerNCT01149356 · 2010-10-01
TERMINATED
RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerNCT01193881 · 2010-08-01
TERMINATED
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid TumorsNCT01131234 · 2010-05-01
COMPLETED
RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By SurgeryNCT01071564 · 2009-11-01
TERMINATED

Common conditions

HER2/Neu Negative4Recurrent Breast Carcinoma4Stage IIIB Breast Cancer4Stage IIIC Breast Cancer4Male Breast Carcinoma3Stage IV Breast Cancer3Adult Solid Neoplasm2Estrogen Receptor Negative2Progesterone Receptor Negative2Recurrent Melanoma2Recurrent Non-Small Cell Lung Carcinoma2Stage IV Non-Small Cell Lung Cancer2Triple-Negative Breast Carcinoma2Adult Anaplastic Astrocytoma1Adult Anaplastic Ependymoma1Adult Anaplastic Oligodendroglioma1Adult Brain Stem Glioma1Adult Giant Cell Glioblastoma1Adult Glioblastoma1Adult Gliosarcoma1Adult Mixed Glioma1Estrogen Receptor Positive1Extensive Stage Lung Small Cell Carcinoma1HER2/Neu Positive1Metastatic Malignant Neoplasm in the Brain1

Trial status mix

TERMINATED5
COMPLETED1

Phase mix

PHASE16
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.